Autism Spectrum Disorder (ASD) - Comprehensive Overview

Definition & Historical Context

1. Deficits in social communication
2. Restricted and repetitive behaviors

Epidemiology

• Prevalence: approximately 1 in 36 children in the US (CDC); some estimates now approach 1-2% of the population
• Males are diagnosed 3-4x more frequently than females
• Average age of diagnosis: ~3.1 years for classic autism, 7.2 years for the former Asperger phenotype
• About 1/3 of children with ASD also have intellectual disability
• In up to 25% of cases, language develops and is subsequently lost - Kaplan & Sadock's Synopsis, p. 393-394

Clinical Features

Core Social Communication Deficits

• Lack of developmentally appropriate social interaction (may appear in year 1-2 of life)
• Failure to develop peer relationships
• Absent or diminished joint attention
• Impaired understanding of social reciprocity, facial expressions, and emotions
• Reduced or absent eye contact

Restricted & Repetitive Behaviors

• Stereotyped motor movements: hand-flapping, toe-walking, rocking
• Insistence on sameness; distress at minor changes
• Intense, idiosyncratic preoccupations with narrow topics
• Restricted patterns of play

Associated Features (Not Diagnostic, But Common)

• Intellectual disability (~1/3)
• Language delay or regression
• ADHD-like inattention and hyperactivity
• Self-injurious behavior
• Sleep disturbances
• Gastrointestinal symptoms
• Anxiety and mood dysregulation - Kaplan & Sadock's Synopsis, p. 393-395

DSM-5 Specifiers

• Severity levels (Level 1, 2, 3 - "requiring support" to "requiring very substantial support")
• With or without intellectual impairment
• With or without language impairment
• Associated with a known genetic/medical condition

Neurobiology & Etiology

Genetics

• Monozygotic twin concordance: 80-92%
• Dizygotic twin concordance: 1-10% (indicating highly multigenic inheritance)
• Sibling recurrence risk: 2-6% (50-100x the population rate)
• Copy number variants (CNVs) are found in 5-10% of autistic individuals vs. 1-3% in controls; these CNVs cluster at loci involved in synapse development, neuronal migration, and axon targeting
• Key genes involve three systems: synapse formation/maintenance, morphogenesis, and calcium regulation/signaling - Kaplan & Sadock's Comprehensive Textbook, p. 898-899

• Fragile X syndrome (FMR1 mutation) - accounts for 3-4% of autism cases
• Tuberous sclerosis (TSC1/TSC2 mutations) - 2-10% of autism cases; affects mTOR pathway
• Rett syndrome (MECP2 mutation) - mostly females; normal development followed by regression
• Phelan-McDermid syndrome (22q13.3 deletion, SHANK3 gene)
• PTEN mutations - associated with macrocephaly and ASD

Immune Dysregulation

• Unbalanced Th1/Th2 cytokine production; reduced NK and T-cell activation
• Elevated TNF, IL-12, IL-1, IL-6, IFN-gamma, and MCP-1
• Reduced anti-inflammatory TGF-beta
• Maternal immune activation (MIA): maternal infections during pregnancy, especially influenza (2x risk) and prolonged maternal fever (3x risk), increase ASD risk
• Maternal autoimmune disease increases child's ASD risk by 34%
• Vaccines do not trigger autism - large epidemiologic studies (including Danish registry data) have not substantiated this claim - Kaplan & Sadock's Comprehensive Textbook, p. 686

Brain Morphology

• Increased brain volume (especially left hemisphere) in early childhood
• Variations in gray and white matter
• Temporal lobe white matter developmental differences
• Abnormal connectivity between brain regions rather than localized lesions
• A 2025 neurobiological mini-review in Frontiers in Psychology notes genetic and morphological findings are essential but still insufficient to explain the full behavioral heterogeneity of ASD

Screening & Diagnosis

Screening Tools

• M-CHAT-R/F (Modified Checklist for Autism in Toddlers, Revised with Follow-up) - recommended at 18 and 24 months by AAP
• ADOS-2 (Autism Diagnostic Observation Schedule) - gold standard observational tool
• ADI-R (Autism Diagnostic Interview-Revised) - structured parent interview
• CARS (Childhood Autism Rating Scale)

Diagnostic Evaluation

• Comprehensive developmental history
• Standardized diagnostic tools (ADOS-2, ADI-R)
• Audiologic evaluation (to rule out hearing loss)
• Genetic testing: chromosomal microarray, Fragile X testing; consider whole exome sequencing
• Neurologic evaluation if regression is present
• No biomarkers currently validated for routine clinical use (though research is active)

Treatment & Management

Behavioral & Developmental Interventions

• Intensive one-to-one therapy (20-40 hours/week)
• Uses reinforcement for social skills, language, and play target behaviors
• Most evidence-based for young children (ages 2-5)

• Naturalistic settings (home, daycare, play)
• Parents as co-therapists
• Integrates ABA with relationship-based approaches

• Parent-implemented; targets "pivotal" gateway social behaviors
• Generalization occurs naturally once core skills are mastered

• Group-based; practices initiating conversations, joint attention, emotion identification, and social problem-solving

Educational Interventions

• TEACCH (Treatment and Education of Autistic and related Communication-handicapped Children) - structured classroom environment
• Speech and language therapy
• Occupational therapy
• Individualized Education Plans (IEPs)

Pharmacological Treatment

Complementary & Alternative Medicine (CAM)

• Dietary interventions (gluten-free/casein-free), omega-3 supplementation, vitamin B6/magnesium, and melatonin are commonly used
• Evidence is limited; clinicians should discuss safety and evidence with families in a non-judgmental manner
• Tetrahydrobiopterin has been studied in double-blind RCTs with mixed results

Prognosis

• Outcomes are highly variable and depend on IQ, language development by age 5, and severity
• Children with normal IQ and functional language by age 5 have the best outcomes
• About 10-20% achieve near-normal independent functioning as adults
• The majority require some degree of lifetime support
• Early diagnosis and intervention are the most powerful predictors of better outcomes

Recent Evidence (2024-2025)

• A 2024 systematic review (PMID 38986177) found that physical exercise therapy significantly improves ASD-related symptoms
• A 2025 systematic review (PMID 41207162) documents burnout as a distinct and under-recognized experience in autistic individuals - relevant for adult care
• Co-occurrence of ASD with ARFID (avoidant/restrictive food intake disorder) is common - a 2025 meta-analysis (PMID 39760303) quantified the prevalence